Moderna Inc (MRNA)
Operating return on assets (Operating ROA)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | -4,239,000 | -2,665,000 | 513,000 | 4,827,000 | 9,420,000 | 13,250,000 | 15,642,000 | 16,257,000 | 13,296,000 | 7,611,000 | 3,818,000 | 634,000 | -763,000 | -618,556 | -514,320 | -536,029 | -546,670 | -569,145 |
| Total assets | US$ in thousands | 18,426,000 | 19,450,000 | 21,884,000 | 24,125,000 | 25,858,000 | 26,056,000 | 26,043,000 | 27,609,000 | 24,669,000 | 20,923,000 | 16,153,000 | 12,694,000 | 7,337,000 | 4,650,870 | 3,486,010 | 2,067,540 | 1,589,420 | 1,590,900 |
| Operating ROA | -23.01% | -13.70% | 2.34% | 20.01% | 36.43% | 50.85% | 60.06% | 58.88% | 53.90% | 36.38% | 23.64% | 4.99% | -10.40% | -13.30% | -14.75% | -25.93% | -34.39% | -35.78% |
December 31, 2023 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $-4,239,000K ÷ $18,426,000K
= -23.01%
The operating return on assets (operating ROA) for Moderna Inc has fluctuated significantly over the past eight quarters. The trend indicates a decreasing performance, with the latest quarter, Q4 2023, showing a negative operating ROA of -23.01%, which is a sharp decline from the previous quarter. This negative operating ROA suggests that the company's operating income generated from its assets was insufficient to cover its operating expenses and capital costs.
Looking back over the quarters, Moderna Inc experienced a steady decrease in its operating ROA, moving from a peak of 60.06% in Q2 2022 to the current low of -23.01% in Q4 2023. This downward trajectory could be a cause for concern as it indicates a deterioration in the company's ability to generate profitability from its operational activities relative to its assets.
It is important for Moderna Inc to closely monitor and address the factors contributing to the negative trend in its operating ROA to improve operational efficiency, maximize asset utilization, and enhance overall financial performance in the future.
Peer comparison
Dec 31, 2023